Context: Metabolic syndrome (MetS) is defined as clustering of risk factors including obesity, dyslipidemia, hyperglycemia, and hypertension, which is associated with increased risk of cardiovascular disease (CVD) and Type 2 diabetes mellitus (T2DM).
ent risk alleles related to the component of MetS could be more effective in the development of MetS (6) .
Previous studies demonstrated that MetS could be heritable in 10% to 30% of the cases (7). In addition, evidences showed the early life origin of MetS (8) .
Several SNPs underlying MetS development in pediatric population have been reported, but the results are inconsistent (9-15) (16-25) (26-36) (37-46). There is not any comprehensive report about different reported risk alleles of MetS in children and adolescents. It is suggested that providing an overview from the available evidences of MetS related SNPs could be helpful in understanding the genomics of MetS and that integrations of both clinical and biological information would help us in better management of the disorder and implementation of genetic base treatment.
Objectives
This review aimed at reviewing all reported SNPs related to childhood MetS. Our findings provide us with baseline information for future genetic studies as well as current information for planning more effective management plans for this group of population, which consequently could decrease the burden of the disease and its related long-term consequences.
Data Sources
This study was designed as a systematic review without meta-analysis in accordance with the preferred reporting item for systematic reviews meta-analysis (PRISMA) statement recommendation for reviewing all reported SNPs related to childhood MetS.
In this review, an electronic literature search was conducted in PubMed and HuGE Navigator database.
The results of population-based epidemiologic studies of human genes since 2001 were extracted from PubMed and HuGE navigator database. Evidences indicated that HuGE Navigator has similar sensitivity but more specificity than PubMed database (47).
Considering that this database retrieved published papers since 2001, we conducted an additional search from PubMed central for all studies published up to April 2016 without any restriction for time and language.
For the HuGE Navigator search, we used the "metabolic syndrome" search term.
For the PubMed search, we used "metabolic syndrome", "child", "adolescents", "pediatrics", "genes", and "polymorphism" terms and the following strategy: ["metabolic syndrome"AND "child" OR "adolescents" OR "pediatrics" AND "genes" OR "polymorphism"].
The latest search was conducted on April 5th, 2016. Human studies with cross-sectional or case-control designs, which contained MetS as outcome and recruited participants younger than 21 years, were included in the review. All definitions of pediatrics MetS were acceptable.
Study Selection and Data Extraction
First step selection was based on title and abstracts. A list of studies was performed accordingly. The full text of the studies were provided and reviewed based on inclusion and exclusion criteria for eligibility. After excluding duplicated studies, the full texts of articles were carefully studied by 2 researchers. The related articles were selected and the irrelevant ones were excluded. Quality of the studies was evaluated by the 2 researchers independently based on the characteristics of the studies and strengthening the reporting of observational studies in epidemiology (STROBE) checklist. Disagreements were resolved by consensus and mutual discussion.
For each finally included article, the following information was extracted: authors, place of the study and/or ethnicity, year of publication, sample size, study design, studied genes and SNPs, and outcome of the study.
Results
In this review during primary literature search, 219 and 1025 articles were identified through PubMed and HuGE Navigators databases, respectively (Figure 1 ).
After checking abstracts and titles, 49 articles from PubMed and 35 articles from HuGE Navigator databases were selected.
During 2 refining steps and after removing duplicates, 42 articles related to the study domain were selected. After quality assessment, 40 studies were selected for text appraisal, of which 38 qualified articles were evaluated at the final step (Figure 1 ). From finally included papers, 20 were conducted on healthy population (9-28), and 18 on obese children (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) (45) (46) .
From reported studies, 19 (50%) had a cross-sectional design, 18 (47.36%) were case-control studies, and 1 (2.64%) was a prospective study. The age range of the studied population was 2 to 20 years. Table 1 displays the details of the  38 included studies. According to the whole data of systematic review results, the number of total population and points of data was 14,536 (8,815 related to healthy population and 5,721 to obese children). Numbers of studied genes and related SNP were 60 (35 in healthy population and 25 in obese children) and 125 (69 in healthy population and 56 in obese children), respectively. From studied SNPs in healthy population, 11 SNPs were associated with occurrence of MetS and 15 with different component of MetS. SNPs of the following genes were associated with MetS: GCK, HNFAα, SHBG, PON1, adiponectin, and obesity related genes (FTO, MC4R, GNPDA2, BDNF,  FAIM2, NPC1, SEC16B, SH2B1, PCSK1, KCTD15, BAT2) , PAI, AT1R, [12] [13] [14] [15] 20, 21, 26, 27) .
SNPs of the following genes were associated with component of MetS: GCK, ACE, ABCA1, PAI, IL6R, IL18, TCF7L2, ADRB2, and TNFα (9, 10, 17, 20, 22, 23, 25, 27, 28) .
SNPs of the following genes did not have any association with MetS or its components: CRP, APOA5, PPARγ, and Tfam (11, 16, 18, 24) .
From studied SNPs in obese children, 11 SNPs were associated with occurrence of MetS and 14 with different component of MetS. SNPs of the following genes were associated with MetS: PNPLA3, APO-A5, NPY, ADRB3, eNOS, and obesity related genes (TMEM18, SH2B1, KCTD15, PCSK1, BDNF, SEC16B, MC4R, and FTO), PLIN, and INSVNTR (29, 31, [33] [34] [35] 37, 42, 44, 46) .
SNPs of the following genes were associated with component of MetS: IL18, NPY, GHR, ACE, FABP4, and PLIN (30, 33, 40) .
SNPs of the following genes did not have any association with MetS or its components: IL6, IL6R, leptinmelanin, leptin, and TNFα (32, 36, 39, 43, 45) .
Discussion
In this study, we reviewed all studies that evaluated the association between different SNPs of various genes with MetS among pediatric population. Our findings indicated that the frequency of the SNPs associated with different component of MetS were higher than those associated with Mets. In healthy population, most of the SNPs associated with MetS component are mainly related to the lipid metabolism, specially triglyceride and HDL (9, 16-18, 20, 22, 25) , but in obese children most of SNPs were related to insulin resistance and lipid metabolism (30, 33, (40) (41) (42) .
We did not find any review study in this field in literature review. Povel et al. have reported their findings from a systematic review and meta-analysis on adult population. They indicated that from 88 studies, which studied 25 genes, minor allele of FTO, TCF7L2, APOA5, APOC3, IL6 genes were more prevalent in MetS cases and a minor allele of CETP gene was less prevalent in participants with MetS. They concluded that lipid metabolism is considered as the most important component in the development of MetS (48).
In current review, most of the evaluated SNPs in healthy population were in association with lipids com-ponent of MetS, and insulin resistance and lipid disorders were the main associated components in obese children. Some previous studies also indicated that the lipid genes and their metabolism pathway have a key role in the genetic background of MetS (49, 50) . Kristiansson et al. conducted a genome-wide association (GWA) study to investigate the association between different identified susceptible loci for MetS with its component traits in 4 Finish cohort populations, with 2637 cases of MetS and 7927 control population. They indicated that susceptibility to MetS is commonly associated with genes and loci related to dyslipidemia and abdominal obesity. The most common related loci were lipid locus APOA1/C3/A4/A5 gene cluster region on Chromosome 11 (49).
In 2 studies, 1 conducted on healthy population and 1 on obese children, the association between obesity related SNPs with MetS was investigated (19, 37) . The results of Zhao et al. study in China on healthy pediatric population revealed that from the studied 11 genes and their related 11SNPs, there were nominal associations between variants of GNPDA, BDNF, and FAIM2 gens with risk of MetS in children. They indicated that combination effect of studied SNPs was more significant in this field (19).
Dusatkova et al. in Czech Republic studied the association between 11 variants of 8 obesity related gens in obese children with MetS. They found that from the studied variants, rs925946 from BDNF gene and the 2 studied variants from MC4R gene were associated with MetS (37).
Considering the findings, it is suggested that combination effect of different obesity related SNPs would result in occurrence of MetS, or as mentioned by Aguilera et al. in Spain, the interaction between obesity related variants and environmental or lifestyle related factors results in development of MetS in children (5).
In the current review, 1 SNP has a protective effect for the occurrence of MetS in children. Alavi-shahri et al. in Iran demonstrated that the AT1R/A1166C polymorphism of AT1R gene have a protective effect on occurrence of MetS in adolescents (24).
Deram et al. in Brazil indicated that the PLIN6 14995A-> T was associated with better weight loss in obese children with MetS (44).
Another finding of our review was that some SNPs from specific genes did not have the same effect in obese and normal weight children.
Although some SNPs from inflammatory factors gens were associated with some component of MetS, none of them had any association with the development of MetS in children (11, 22, 23, 28, 30, 43, 45) .
The implications of this review are that we can use the data of current review to design more epidemiological as well as interventional studies in the field of childhood Mets. Our data can be used for future epigenetic studies.
This review had some limitations. The number of studies included in this review was not large enough and there were not SNPs to perform meta-analysis.
The strength of this review was that no similar study has been conducted in this field on pediatrics population.
Conclusions
The findings of this review revealed that most reported SNPs related to MetS in children are associated with its components than with MetS. Most of the reported loci are related to lipid disorders, mainly triglyceride and HDL and insulin resistance. Furthermore, the polymorphisms were not similar in obese and non-obese children.
Combination effect of most of the reported SNPs or their interaction with environmental factors is more effective in developing MetS in children. Thus, it is highly recommended to conduct more studies to evaluate the interaction of different SNPs related to the components of MetS or interaction of SNPs-phenotype (such as obesity) in the occurrence of MetS. The association between rs8066560 variant in the sterol regulatory element-binding protein 1 (SREBP-1) and miR-33b genes with insulin resistance 200 participants aged 9 -19 y (100 with MetS and 100 healthy controls)
SREBP-1 and miR-33b genes rs8066560 There was not any significant association between rs8066560 polymorphism and MetS, hyperglycemia, and insulin resistance in studied population. They found a significant association between rs8066560 polymorphism and LDL-C levels in adolescents.
12
Fatemi et al. (18) 
They demonstrated a nominal associations between variants of GNPDA, BDNF and FAIM2 with risk of MetS in children. They indicated that combination effect of studied SNPs were more significant in this field. TCF7L2 rs6585194, rs7919409, rs11196219, rs4918792, rs10749127, rs11196224, rs7085532, rs17130188, rs10787475, rs12775879, rs290498, rs290487, rs290481, (rs7079711, rs4506565, rs7903146, rs12243326, rs7895340, rs12255372 From 19 SNPs, two of them rs290487 and rs10749127 C were associated with insulin resistance and some features of MetS including blood pressure and triglyceride, respectively. The rs1042714 SNP was associated with higher body fat, waist circumference, and free fatty acids. The rs1042717 SNP was associated with higher body weight, fasting insulin, and HOMA score. The rs1042714, rs1042717, rs1042718, and rs1042719 was associated with higher body weight, fasting insulin, and HOMA score.
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